Medicare Enrolled
Dr. Daniel Ricchiuti, M.D.
Urology Physician · Youngstown, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ricchiuti from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ricchiuti?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ricchiuti
Dr. Daniel Ricchiuti is an urology physician in Youngstown, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ricchiuti performed 4,191 Medicare services across 2,769 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ricchiuti received a total of $6,507 from 54 pharmaceutical and/or device companies across 220 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ricchiuti is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 10% volume in OH
$6,507 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,191
Medicare services
Top 10% in OH for urology physician
2,769
Unique beneficiaries
$57
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~210 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
863 | $3 | $14 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
548 | $81 | $506 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
506 | $47 | $190 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 423 | $133 | $578 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
314 | $8 | $12 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
264 | $7 | $38 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
199 | $58 | $356 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
99 | $101 | $539 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
92 | $167 | $903 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
84 | $19 | $99 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
79 | $24 | $124 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
71 | $46 | $185 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
68 | $61 | $282 |
| Additional urethral implant in prostate Placement of an additional implant into the urethra within the prostate gland using an endoscope. |
67 | $38 | $205 |
| Simple change of bladder tube | 64 | $70 | $378 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
63 | $99 | $534 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
59 | $36 | $140 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
48 | $110 | $627 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
45 | $42 | $246 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
31 | $14 | $87 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
21 | $227 | $1,214 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
19 | $6 | $57 |
| Urethral implant insertion in prostate A single implant is placed into the urethra within the prostate gland using an endoscope. |
19 | $143 | $835 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
19 | $126 | $708 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
17 | $557 | $2,903 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
17 | $64 | $398 |
| Complicated insertion of bladder tube | 15 | $105 | $579 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
15 | $327 | $1,655 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
15 | $74 | $405 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
13 | $24 | $257 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
12 | $57 | $305 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
11 | $264 | $1,500 |
| Complex urodynamic pressure measurement A test that measures the pressure of urine flow in the bladder along with urethral and voiding pressures. |
11 | $270 | $1,518 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.0% high complexity
10.2% medium
87.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,507
Total received (2018-2024)
Avg $930/year across 7 years
Top 26% in OH for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
220
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,662 (56.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,788 (27.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,057 (16.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$676
2023
$922
2022
$789
2021
$650
2020
$2,051
2019
$607
2018
$813
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Sumitomo Pharma America, Inc.
$108
BIOTISSUE HOLDINGS INC.
$84
Astellas Pharma US Inc
$84
PFIZER INC.
$79
ABBVIE INC.
$55
Verity Pharmaceuticals Inc.
$54
Medtronic, Inc.
$49
Laborie Medical Technologies Corp.
$38
Dendreon Pharmaceuticals LLC
$23
Merck Sharp & Dohme LLC
$19
Tempus AI, Inc
$17
Novartis Pharmaceuticals Corporation
$17
BLUEWIND MEDICAL
$17
Olympus America Inc.
$16
AstraZeneca Pharmaceuticals LP
$16
Top 3 companies account for 41.0% of 2024 payments
All-time payments by company (2018-2024) ›
GENZYME CORPORATION
$1,788
Astellas Pharma US Inc
$1,320
PFIZER INC.
$329
Bayer HealthCare Pharmaceuticals Inc.
$320
Teleflex LLC
$284
Janssen Biotech, Inc.
$265
Dendreon Pharmaceuticals LLC
$250
Sumitomo Pharma America, Inc.
$250
Merck Sharp & Dohme LLC
$123
Blue Earth Diagnostics Limited
$119
Medtronic, Inc.
$107
Ethicon US, LLC
$87
BIOTISSUE HOLDINGS INC.
$84
Verity Pharmaceuticals Inc.
$81
Novartis Pharmaceuticals Corporation
$77
NeoTract Inc.
$58
ABBVIE INC.
$55
UroGen Pharma, Inc.
$49
DENTSPLY IH Inc.
$45
Tolmar, Inc.
$44
TOLMAR Pharmaceuticals, Inc.
$43
Myovant Sciences Inc.
$42
Ethicon Inc.
$40
Allergan Inc.
$39
AbbVie, Inc.
$38
Laborie Medical Technologies Corp.
$38
PROCEPT BioRobotics Corporation
$33
Antares Pharma, Inc.
$33
Retrophin, Inc.
$32
AstraZeneca Pharmaceuticals LP
$29
Avadel Specialty Pharmaceuticals, LLC
$25
C. R. Bard, Inc. & Subsidiaries
$25
Sun Pharmaceutical Industries Inc.
$23
Ferring Pharmaceuticals Inc.
$23
Amgen Inc.
$22
UROVANT SCIENCES INC
$20
CONMED Corporation
$18
Boston Scientific Corporation
$18
Axonics, Inc.
$18
Tempus AI, Inc
$17
BLUEWIND MEDICAL
$17
Olympus America Inc.
$16
Allergan, Inc.
$16
Mission Pharmacal Company
$15
BOSTON SCIENTIFIC CORPORATION
$15
Axonics Modulation Technologies, Inc.
$15
Coloplast Corp
$14
Travere Therapeutics, Inc.
$14
Clarus Therapeutics Inc.
$13
DAVOL INC.
$13
AbbVie Inc.
$13
SRS Medical Systems, Inc.
$12
UROGEN PHARMA, INC.
$11
HealthTronics Mobile Solutions, LLC
$9
Top 3 companies account for 52.8% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · AIRSEAL · AMS 700 CXR RTE KIT · AQUABEAM ROBOTIC SYSTEM · AquaBeam Robotic System · Aquoral · Axonics r-SNM System · Axumin · BOTOX · ELIGARD · ERLEADA · GEMTESA · HARMONIC Product Family · INLAY OPTIMA · INTERSTIM · JATENZO · JELMYTO · JEVTANA · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LithoVue · LoFric · Lupron · MYRBETRIQ · Mobile Cryoblation Services · Monarch Platform · Myrbetriq · NOCDURNA · Noctiva · Nubeqa · ORGOVYX · OTREXUP · Optilume BPH Drug Coated Balloon Catheter · PLUVICTO · PROGEL · PROVENGE · Porges Coloplast · Prolia · REVI · SWIFTSET · TOVIAZ · Trelstar · UROLIFT · UroCuff · UroLift · UroLift System · V-LOC 180 · XTANDI · Xofigo · Xtandi · YONSA · YONSA (abiraterone acetate) · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (56%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
16
Per 100K population
7.0
County median income
$55,576
Nearest hospital
GENERATIONS BEHAVIORAL HEALTH-YOUNGSTOWN LLC
1.0 mi
1.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ricchiuti is a clinical cardiology specialist, with above-average Medicare volume (top 10% in OH), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ricchiuti experienced with urinalysis, manual?
Based on Medicare claims data, Dr. Ricchiuti performed 863 urinalysis, manual services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ricchiuti receive payments from pharmaceutical companies?
Yes. Dr. Ricchiuti received a total of $6,507 from 54 companies across 220 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ricchiuti's costs compare to other urology physicians in Youngstown?
Dr. Ricchiuti's average Medicare payment per service is $57. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ricchiuti) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Youngstown
Browse urology physicians in Youngstown ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in OH
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in OH
Which OH urology physicians receive the most from drug and device companies.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology